New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS
Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measure...
Gespeichert in:
Veröffentlicht in: | Japanese Journal of Cardiovascular Surgery 2011/01/15, Vol.40(1), pp.31-33 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | jpn |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 33 |
---|---|
container_issue | 1 |
container_start_page | 31 |
container_title | Japanese Journal of Cardiovascular Surgery |
container_volume | 40 |
creator | Akasu, Koji Mori, Ryusuke Ueda, Tomohiro Tomoeda, Hiroshi Arinaga, Koichi Fukunaga, Shuji Aoyagi, Shigeaki |
description | Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measurement with the CoaguChek XS® with the conventional blood testing method. The correlation coefficient was 0.916, and the regression line was Y=0.8027X+0.3399. In addition, drawing blood using the CoaguChek XS® was very effective in the reported pain reduction in patients. |
doi_str_mv | 10.4326/jjcvs.40.31 |
format | Article |
fullrecord | <record><control><sourceid>jstage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_4326_jjcvs_40_31</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>article_jjcvs_40_1_40_1_31_article_char_en</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1301-8dd885643af52ff33e9b806b5a898c49607a90ab27e34e955e7cb57698ef160e3</originalsourceid><addsrcrecordid>eNpF0D1PwzAQBmALgURVOvEHvKOUu9hOnI0S8SVVMLRFbJbj2mlKiJEdQP33BIrKcjfco1e6l5BzhClnaXa53ZrPOOUwZXhERiglSziCPCYjSKVIkOf8lExibCqANMsRkI_I9aP9orOub4zX9Uer-8Z3tPRdH3xLnQ906Xe-8sn8ebagq9h0Ne03dhCDLjf2lb4szsiJ0220k789Jqvbm2V5n8yf7h7K2TwxyAATuV5LKTLOtBOpc4zZopKQVULLQhpeZJDrAnSV5pZxWwhhc1OJPCukdZiBZWNysc81wccYrFPvoXnTYacQ1E8D6rcBxUExHPTVXm9jr2t7sDoMv7b23-J-MDyczEYHZTv2DVLXZZ8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS</title><source>J-STAGE Free</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Akasu, Koji ; Mori, Ryusuke ; Ueda, Tomohiro ; Tomoeda, Hiroshi ; Arinaga, Koichi ; Fukunaga, Shuji ; Aoyagi, Shigeaki</creator><creatorcontrib>Akasu, Koji ; Mori, Ryusuke ; Ueda, Tomohiro ; Tomoeda, Hiroshi ; Arinaga, Koichi ; Fukunaga, Shuji ; Aoyagi, Shigeaki</creatorcontrib><description>Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measurement with the CoaguChek XS® with the conventional blood testing method. The correlation coefficient was 0.916, and the regression line was Y=0.8027X+0.3399. In addition, drawing blood using the CoaguChek XS® was very effective in the reported pain reduction in patients.</description><identifier>ISSN: 0285-1474</identifier><identifier>EISSN: 1883-4108</identifier><identifier>DOI: 10.4326/jjcvs.40.31</identifier><language>jpn</language><publisher>The Japanese Society for Cardiovascular Surgery</publisher><subject>anticoagulation therapy ; CoaguChek XS ; PT-INR ; Toyobo-LVAS ; warfarin</subject><ispartof>Japanese Journal of Cardiovascular Surgery, 2011/01/15, Vol.40(1), pp.31-33</ispartof><rights>2011 The Japanese Society for Cardiovascular Surgery</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,27901,27902</link.rule.ids></links><search><creatorcontrib>Akasu, Koji</creatorcontrib><creatorcontrib>Mori, Ryusuke</creatorcontrib><creatorcontrib>Ueda, Tomohiro</creatorcontrib><creatorcontrib>Tomoeda, Hiroshi</creatorcontrib><creatorcontrib>Arinaga, Koichi</creatorcontrib><creatorcontrib>Fukunaga, Shuji</creatorcontrib><creatorcontrib>Aoyagi, Shigeaki</creatorcontrib><title>New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS</title><title>Japanese Journal of Cardiovascular Surgery</title><addtitle>J. J. C. V. S.</addtitle><description>Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measurement with the CoaguChek XS® with the conventional blood testing method. The correlation coefficient was 0.916, and the regression line was Y=0.8027X+0.3399. In addition, drawing blood using the CoaguChek XS® was very effective in the reported pain reduction in patients.</description><subject>anticoagulation therapy</subject><subject>CoaguChek XS</subject><subject>PT-INR</subject><subject>Toyobo-LVAS</subject><subject>warfarin</subject><issn>0285-1474</issn><issn>1883-4108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNpF0D1PwzAQBmALgURVOvEHvKOUu9hOnI0S8SVVMLRFbJbj2mlKiJEdQP33BIrKcjfco1e6l5BzhClnaXa53ZrPOOUwZXhERiglSziCPCYjSKVIkOf8lExibCqANMsRkI_I9aP9orOub4zX9Uer-8Z3tPRdH3xLnQ906Xe-8sn8ebagq9h0Ne03dhCDLjf2lb4szsiJ0220k789Jqvbm2V5n8yf7h7K2TwxyAATuV5LKTLOtBOpc4zZopKQVULLQhpeZJDrAnSV5pZxWwhhc1OJPCukdZiBZWNysc81wccYrFPvoXnTYacQ1E8D6rcBxUExHPTVXm9jr2t7sDoMv7b23-J-MDyczEYHZTv2DVLXZZ8</recordid><startdate>20110115</startdate><enddate>20110115</enddate><creator>Akasu, Koji</creator><creator>Mori, Ryusuke</creator><creator>Ueda, Tomohiro</creator><creator>Tomoeda, Hiroshi</creator><creator>Arinaga, Koichi</creator><creator>Fukunaga, Shuji</creator><creator>Aoyagi, Shigeaki</creator><general>The Japanese Society for Cardiovascular Surgery</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20110115</creationdate><title>New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS</title><author>Akasu, Koji ; Mori, Ryusuke ; Ueda, Tomohiro ; Tomoeda, Hiroshi ; Arinaga, Koichi ; Fukunaga, Shuji ; Aoyagi, Shigeaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1301-8dd885643af52ff33e9b806b5a898c49607a90ab27e34e955e7cb57698ef160e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2011</creationdate><topic>anticoagulation therapy</topic><topic>CoaguChek XS</topic><topic>PT-INR</topic><topic>Toyobo-LVAS</topic><topic>warfarin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akasu, Koji</creatorcontrib><creatorcontrib>Mori, Ryusuke</creatorcontrib><creatorcontrib>Ueda, Tomohiro</creatorcontrib><creatorcontrib>Tomoeda, Hiroshi</creatorcontrib><creatorcontrib>Arinaga, Koichi</creatorcontrib><creatorcontrib>Fukunaga, Shuji</creatorcontrib><creatorcontrib>Aoyagi, Shigeaki</creatorcontrib><collection>CrossRef</collection><jtitle>Japanese Journal of Cardiovascular Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akasu, Koji</au><au>Mori, Ryusuke</au><au>Ueda, Tomohiro</au><au>Tomoeda, Hiroshi</au><au>Arinaga, Koichi</au><au>Fukunaga, Shuji</au><au>Aoyagi, Shigeaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS</atitle><jtitle>Japanese Journal of Cardiovascular Surgery</jtitle><addtitle>J. J. C. V. S.</addtitle><date>2011-01-15</date><risdate>2011</risdate><volume>40</volume><issue>1</issue><spage>31</spage><epage>33</epage><pages>31-33</pages><issn>0285-1474</issn><eissn>1883-4108</eissn><abstract>Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measurement with the CoaguChek XS® with the conventional blood testing method. The correlation coefficient was 0.916, and the regression line was Y=0.8027X+0.3399. In addition, drawing blood using the CoaguChek XS® was very effective in the reported pain reduction in patients.</abstract><pub>The Japanese Society for Cardiovascular Surgery</pub><doi>10.4326/jjcvs.40.31</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0285-1474 |
ispartof | Japanese Journal of Cardiovascular Surgery, 2011/01/15, Vol.40(1), pp.31-33 |
issn | 0285-1474 1883-4108 |
language | jpn |
recordid | cdi_crossref_primary_10_4326_jjcvs_40_31 |
source | J-STAGE Free; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | anticoagulation therapy CoaguChek XS PT-INR Toyobo-LVAS warfarin |
title | New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T22%3A52%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20Anticoagulation%20Control%20for%20Toyobo-LVAS%20Using%20the%20CoaguChek%20XS&rft.jtitle=Japanese%20Journal%20of%20Cardiovascular%20Surgery&rft.au=Akasu,%20Koji&rft.date=2011-01-15&rft.volume=40&rft.issue=1&rft.spage=31&rft.epage=33&rft.pages=31-33&rft.issn=0285-1474&rft.eissn=1883-4108&rft_id=info:doi/10.4326/jjcvs.40.31&rft_dat=%3Cjstage_cross%3Earticle_jjcvs_40_1_40_1_31_article_char_en%3C/jstage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |